Deltagen buys Benten Bio to expand biopharmaceutical business
Deltagen, a San Mateo, Calif.-based drug distribution company, has acquired Benten BioServices, a privately-held firm that takes care of contracting for the pharmaceutical industry, according to VentureWire. Delaware-headquartered Benten previously raised funds from Life Sciences Greenhouse and Penn Venture Partners.
Next Story: Wireless equipment co. Meru files for IPO
Previous Story: Sequoia charges ahead on new $1B fund
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
